Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aminoglycoside dosage regimens. Is once a day enough?

Literature DB >> 8119044

Aminoglycoside dosage regimens. Is once a day enough?

W N Hustinx¹, I M Hoepelman.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1993 PMID： 8119044 DOI： 10.2165/00003088-199325060-00002

Source DB: PubMed Journal: Clin Pharmacokinet ISSN： 0312-5963 Impact factor: 6.447

× No keyword cloud information.

37 in total

1. Once daily dosing of aminoglycoside: one step forward.

Authors: J C Pechère; W A Craig; F Meunier
Journal: J Antimicrob Chemother Date: 1991-05 Impact factor: 5.790

2. The postantibiotic effect.

Authors: W A Craig; B Vogelman
Journal: Ann Intern Med Date: 1987-06 Impact factor: 25.391

3. Postantibiotic suppression of bacterial growth.

Authors: R W Bundtzen; A U Gerber; D L Cohn; W A Craig
Journal: Rev Infect Dis Date: 1981 Jan-Feb

4. Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections.

Authors: P J de Vries; R P Verkooyen; P Leguit; H A Verbrugh
Journal: Eur J Clin Microbiol Infect Dis Date: 1990-03 Impact factor: 3.267

Review 5. Once-daily aminoglycoside administration: new strategies for an old drug.

Authors: J M Kovarik; I M Hoepelman; J Verhoef
Journal: Eur J Clin Microbiol Infect Dis Date: 1989-09 Impact factor: 3.267

6. Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia.

Authors: E T Anderson; L S Young; W L Hewitt
Journal: Am J Med Date: 1976-10 Impact factor: 4.965

7. Once versus thrice daily gentamicin in patients with serious infections.

Authors: J M Prins; H R Büller; E J Kuijper; R A Tange; P Speelman
Journal: Lancet Date: 1993-02-06 Impact factor: 79.321

8. Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin.

Authors: P M Tulkens
Journal: J Antimicrob Chemother Date: 1991-05 Impact factor: 5.790

9. Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man.

Authors: M E De Broe; L Verbist; G A Verpooten
Journal: J Antimicrob Chemother Date: 1991-05 Impact factor: 5.790

10. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.

Authors: Thierry Calandra; J Klastersky; H Gaya; M P Glauser; F Meunier; S H Zinner
Journal: N Engl J Med Date: 1987-12-31 Impact factor: 91.245

10 in total

1. Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy.

Authors: Lana Nezic; Adrian Derungs; Marcel Bruggisser; Sarah Tschudin-Sutter; Stephan Krähenbühl; Manuel Haschke
Journal: Eur J Clin Pharmacol Date: 2014-04-23 Impact factor: 2.953

Aminoglycoside dosage regimens. Is once a day enough?

1. Once daily dosing of aminoglycoside: one step forward.

2. The postantibiotic effect.

3. Postantibiotic suppression of bacterial growth.

4. Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections.

Review 5. Once-daily aminoglycoside administration: new strategies for an old drug.

6. Simultaneous antibiotic levels in "breakthrough" gram-negative rod bacteremia.

7. Once versus thrice daily gentamicin in patients with serious infections.

8. Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin.

9. Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man.

10. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.

1. Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy.

2. The economic impact of once-daily versus conventional administration of gentamicin and tobramycin.

3. Meropenem versus cefuroxime plus gentamicin for treatment of serious infections in elderly patients.

Review 4. Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Review 5. Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly.

6. Pharmacokinetics and dosing regimen of aminosidine in the dog.

Review 7. What is the evidence for once-daily aminoglycoside therapy?

Review 8. Cost considerations in therapeutic drug monitoring of aminoglycosides.

Review 9. Parenteral aminoglycoside therapy. Selection, administration and monitoring.

10. Influence of dose on the disposition kinetics of netilmicin in the isolated kidney of the rat.